Cargando…
A High-Risk Patient With COVID-19 Vaccine Hesitancy Successfully Treated With Monoclonal Antibodies Through Two Major Surges
Vaccine hesitancy remains a significant challenge in managing the current pandemic despite highly effective vaccines in the United States. Monoclonal antibodies (mAb) are an essential addition to coronavirus disease 2019 (COVID-19) treatment, along with oral antiviral agents (OAA), for non-hospitali...
Autores principales: | Gurjar, Hitesh, Ghazanfar, Haider, Haider, Asim, Hernandez, Nolberto, Jyala, Abhilasha, Chilimuri, Sridhar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971087/ https://www.ncbi.nlm.nih.gov/pubmed/35371707 http://dx.doi.org/10.7759/cureus.22721 |
Ejemplares similares
-
Outcomes of Monoclonal Antibody Infusion Treatment During Delta (B.1.617.2) and Omicron (B.1.1.529) COVID 19 Variant Surges among Vaccinated and Unvaccinated Patients
por: Ghazanfar, Haider, et al.
Publicado: (2022) -
Necrotizing Fasciitis in a Patient with Metastatic Clear Cell Ovarian Carcinoma Treated with Bevacizumab
por: Haider, Asim, et al.
Publicado: (2022) -
Impact of COVID-19 on the Gastrointestinal Tract: A Clinical Review
por: Ghazanfar, Haider, et al.
Publicado: (2022) -
Mo1330: THE IMPACT OF COVID-19 ON ALCOHOLIC LIVER DISEASES IN A PREDOMINANTLY AFRICAN AMERICAN AND HISPANIC COMMUNITY
por: Sun, Haozhe, et al.
Publicado: (2022) -
Diagnostic Challenge of Small Bowel Neuroendocrine Tumor in a Young Female Patient
por: Lee, Somin, et al.
Publicado: (2023)